Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07343297 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ask Questions About Clinical Trials

Study acronym: ASQ-CT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 30, 2026 → Dec 30, 2027
See other at-risk trials from Barbara Ann Karmanos Cancer Institute

Record History

  1. Primary completion pushed from Dec 30, 2026 to Dec 30, 2027v2 Show 4 more changesShow less
    • Recruitment opened
    • Start date: Apr 30, 2026 to Dec 30, 2026
    • Trial sites expanded: 0 → 8 locations
    • Study completion pushed from Apr 5, 2027 to Apr 5, 2028
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall goal of this study is to assess the implementation of the Ask Questions about Clinical Trials (ASQ-CT) brochure, a patient-focused communication tool previously demonstrated to improve patient-provider communication about clinical trials. Participants will be given the ASQ-CT brochure at Time 1 (baseline) and participants will complete a questionnaire at three timepoints, baseline (Time 1), Pre-Research Visit (Time 2), and Post-Research Visit (Time 3).
Trial Details
NCT Number NCT07343297
Lead Sponsor Barbara Ann Karmanos Cancer Institute
Conditions
(from sponsor)		 Oncology, Cardiac Disease, Neurologic Disorder
Related terms Heart Diseases, Neoplasms, Nervous System Diseases
Enrollment 293 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov